Cargando…
Astragaloside IV alleviates senescence of vascular smooth muscle cells through activating Parkin-mediated mitophagy
Astragaloside IV (AS-IV), as one of the main active components of Astragalus membranaceus, has been reported to have cardiovascular protective effects. However, the role and molecular mechanism of AS-IV in vascular senescence have not been clearly stated. The in vitro aging model was constructed usi...
Autores principales: | Li, Huijun, Xu, Jialin, Zhang, Yanan, Hong, Lei, He, Zhijian, Zeng, Zhiheng, Zhang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515037/ https://www.ncbi.nlm.nih.gov/pubmed/35925474 http://dx.doi.org/10.1007/s13577-022-00758-6 |
Ejemplares similares
-
Regulatory Effects of Astragaloside IV on Hyperglycemia-Induced Mitophagy in Schwann Cells
por: Wei, Xiaoyi, et al.
Publicado: (2022) -
Beneficial effects of astragaloside IV against angiotensin II-induced mitochondrial dysfunction in rat vascular smooth muscle cells
por: LU, YAO, et al.
Publicado: (2015) -
Astragaloside IV alleviates heart failure by modulating Nrf-2
por: Feng, Wenxiao, et al.
Publicado: (2022) -
RhoA rescues cardiac senescence by regulating Parkin-mediated mitophagy
por: Soh, Joanne Ern Chi, et al.
Publicado: (2023) -
Astragaloside IV inhibits astrocyte senescence: implication in Parkinson’s disease
por: Xia, Mei-Ling, et al.
Publicado: (2020)